Active ingredientDimethyl FumarateCat. No. P-D130-001CAS 624-49-7Family · Pharmaceutical analytical standards
Dimethyl Fumarate
An ester of fumaric acid taken by mouth for psoriasis, in Germany since 1994 in a mixture with other fumarates, and for relapsing multiple sclerosis, in the United States since 2013 and in Europe since 2014; in the body it becomes monomethyl fumarate. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It all began with a hypothesis by the German chemist Walter Schweckendiek, who in 1959 blamed psoriasis on a disturbance of fumaric acid in the Krebs cycle: the theory did not hold up, the treatment did.
Go to the active ingredient →Active ingredientDimethyl FumarateCat. No. P-D130-001CAS 624-49-7
Pharmacopoeial impurityDimethyl Fumarate USP Related Compound ACat. No. P-D130-002CAS 2756-87-8
Isotopically labelledDimethyl-d6 FumarateCat. No. P-D130-003CAS 66487-95-4
Isotopically labelledMonomethyl Fumarate-d3Cat. No. P-D130-004CAS 1616345-41-5
Isotopically labelledMonomethyl Fumarate-d5Cat. No. P-D130-005CAS 1616345-45-9
ImpurityBis(2-ethylhexyl) FumarateCat. No. P-D130-006CAS 141-02-6
ImpurityDiisopropyl FumarateCat. No. P-D130-007CAS 7283-70-7
ImpurityDimethyl Fumarate DimerCat. No. P-D130-008CAS 14495-41-1
ImpurityDimethyl Fumarate Impurity 1Cat. No. P-D130-009CAS 63119-87-9
ImpurityDimethyl MaleateCat. No. P-D130-010CAS 624-48-6
ImpurityEthyl Methyl FumarateCat. No. P-D130-011CAS 4749-70-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.